The dopamine D2 agonist LY 141865, but not the D1 agonist SKF 38393, reverses parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset
- 1 June 1985
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 57 (1), 37-41
- https://doi.org/10.1016/0304-3940(85)90037-0
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmosetNeuroscience Letters, 1984
- Unilateral striatal dopamine denervation: Reduced motor inhibitory effects of dopamine antagonists revealed in models of asymmetric and circling behaviourNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1984
- The Dopamine/Neuroleptic ReceptorCanadian Journal of Neurological Sciences, 1984
- Interactions of novel dopaminergic ligands with D-1 and D-2 dopamine receptorsLife Sciences, 1982
- Evidence that LY-141865 specifically stimulates the D-2 dopamine receptorNature, 1981
- The pharmacological evaluation of pergolide mesylate as a potential anti-Parkinson agentNeuropharmacology, 1980
- The role of D-1 and D-2 receptorsNature, 1980
- Multiple receptors for dopamineNature, 1979
- THE EFFECT OF BROMOCRIPTINE ON RAT STRIATAL ADENYLATE CYCLASE AND RAT BRAIN MONOAMINE METABOLISMJournal of Neurochemistry, 1978
- The central effects of a novel dopamine agonistEuropean Journal of Pharmacology, 1978